Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

After the JUPITER trial showed that individuals with LDL cholesterols < 130 mg/dL, but high sensitivity CRP > 2.0 benefited from statin therapy, there has been considerable interest in using biomarkers for individualizing treatment.

Individualized Medicine by Biomarkers